Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

1863445 Title: NOUVELLE FORMULATION PHARMACEUTIQUE CONTENANT UN BIGUANIDE ET UN DERIVE DE THIAZOLIDINEDIONE

  • Data
  • Documents

Basic information

Application number:
067381707
WO application number:
US2006009082
Type:
European patent granted for BE
Status:
Deemed Void
Publication number:
1863445
WO publication number:
WO2006107528
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
13/03/2006
Grant date:
11/05/2016
EP publication date:
12/12/2007
WO publication date:
12/10/2006
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
11/05/2016
EP B1 publication date:
11/05/2016
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
13/03/2026

Applicant

1

Name:
Watson Pharmaceuticals, Inc.
Legal Form:
From:
11/05/2016
Address:
311 Bonnie Circle, Corona, CA 92880, United States (US)
To:

2

Name:
Takeda Pharmaceutical Company Limited
Legal Form:
From:
11/05/2016
Address:
1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, Japan (JP)
To:

Inventor

1

Name:
OKOCHI, Kazuhiro, c/o Takeda Pharma. Co. Ltd.
Legal Form:
Address:
Osaka-shi, Osaka, Japan (JP)

2

Name:
NANGIA, Avinash
Legal Form:
Address:
Lincoln, Rl 02865, United States (US)

3

Name:
LODIN, Unchalee
Legal Form:
Address:
Weston, FL 33332, United States (US)

4

Name:
CARDINAL, Jack, R.
Legal Form:
Address:
Wilmington, NC 28412, United States (US)

Priority

Priority patent number:
93742
Priority date:
30/03/2005
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 9/00; A61K 9/20; A61K 31/155; A61K 31/425; A61K 31/426; A61K 45/06;

Publication

European Patent Bulletin

Issue number:
201619
Publication date:
11/05/2016
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
31/03/2017
Annual fee number:
12
Annual fee amount:
240 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer: